Physician profile
Max Ahn
NPI 1548224462
$9,680.45
in general payments reported to CMS, 2019-2025
33 companies · $2,533 in 2025
The $2,533 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,262 · 2020: $118 · 2021: $467 · 2022: $611 · 2023: $588 · 2024: $1,101 · 2025: $2,533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,821 · Travel and Lodging: $1,401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,821.37 |
| Travel and Lodging | $1,401.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,093.05 | 2019-2022 | |
| Procept Biorobotics Corporation | $1,950.35 | 2024-2025 | Aquabeam System |
| Dendreon Pharmaceuticals LLC | $970.85 | 2019-2025 | Provenge |
| Boston Scientific Corporation | $350.76 | 2019-2025 | Lithovue, Ams 700 |
| Janssen Biotech, INC. | $300.31 | 2023-2024 | Erleada |
| Teleflex LLC | $258.65 | 2022 | |
| Abbvie INC. | $223.52 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $142.11 | 2023-2025 | |
| Pfizer INC. | $128.53 | 2021-2025 | |
| Immunitybio, INC. | $118.90 | 2025 | |
| Davol INC. | $107.87 | 2024 | Arista Ah Flexitip |
| Cook Medical LLC | $105.45 | 2024 | Cook, Litho 150 |
| Ferring Pharmaceuticals INC. | $98.28 | 2020 | |
| Janssen Scientific Affairs, LLC | $92.26 | 2019 | |
| Tolmar, INC. | $88.08 | 2023-2025 | Jatenzo, Eligard |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $83.63 | 2022 | |
| Axonics, INC. | $61.72 | 2022-2024 | Axonics |
| Sumitomo Pharma America, INC. | $53.91 | 2024-2025 | Orgovyx, Gemtesa |
| Merck Sharp & Dohme LLC | $50.79 | 2025 | Keytruda, Lynparza |
| Calyxo, INC. | $45.03 | 2024-2025 | Cvac Aspiration System |
| Astellas Pharma US INC | $43.78 | 2020-2022 | |
| Urogen Pharma, INC. | $39.74 | 2023-2025 | Jelmyto |
| Olympus America INC. | $37.48 | 2025 | Itind System |
| Smith+Nephew, INC. | $32.09 | 2025 | Stravix Pl, Stravix |
| Novartis Pharmaceuticals Corporation | $30.54 | 2024 | |
| Profound Medical Corp. | $28.01 | 2025 | Tulsa-Pro |
| Tolmar Pharmaceuticals, INC. | $26.57 | 2019 | |
| Telix Pharmaceuticals | $22.36 | 2024 | Illuccix |
| Astrazeneca Pharmaceuticals Lp | $22.05 | 2025 | Lynparza |
| Conmed Corporation | $20.85 | 2022 | |
| Tempus Ai, INC | $17.90 | 2024 | |
| 180 Medical, INC. | $17.75 | 2023 | |
| Mimedx Group, INC. | $17.28 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Max Ahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.